drugset / Trial / NCT00986102
PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
Phase 4
Completed
216 enrolled
Janssen Research & Development, LLC
Johnson & Johnson (Hong Kong) Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to understand the utilization patterns of doripenem in Asia Pacific, including the profile of the patients treated with carbapenems.
Timeline
- Start
- 2009-07-17
- Primary completion
- 2011-09-05
- Completion
- 2011-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doripenem | Small molecule | 500 mg | Intravenous |